The companies say 440 people will be given the vaccine in the US, with the results due by December.
from BBC News - Business https://ift.tt/3jAxdiG
Thursday, September 3, 2020
Home »
England business news
,
latest business news
,
UK business news
» Coronavirus vaccine trial begun by drug firms GSK and Sanofi
Coronavirus vaccine trial begun by drug firms GSK and Sanofi
Related Posts:
Asia stocks prove resilient to US riots as S&P futures bounceAsian shares pushed to three-month highs on Monday as progress on opening up economies helped offset jitters over riots in U.S. cities and unease over Washington's power struggle with Beijing. from Reuters: Business News… Read More
Oil prices slip as wary traders eye upcoming OPEC+ meetingOil prices fell nearly 1% on Monday as traders hedged bets with the Organization of the Petroleum Exporting Countries (OPEC) considering meeting as soon as this week to discuss whether to extend record production cuts beyond … Read More
Asia's factory pain worsens as China's recovery fails to lift demandAsia's factory pain deepened in May as the slump in global trade caused by the coronavirus pandemic worsened, with export powerhouses Japan and South Korea suffering the sharpest declines in business activity in more than a d… Read More
Oil prices edge down as wary traders eye upcoming OPEC+ meetingOil prices edged down on Monday as traders took profits, with the Organization of the Petroleum Exporting Countries (OPEC) considering meeting as soon as this week to discuss whether to extend record production cuts beyond en… Read More
Asia stocks reach 3-month peaks, resilient to U.S. riotsAsian shares pushed to three-month highs on Monday as progress on opening up economies helped offset jitters over riots in U.S. cities and unease over Washington's power struggle with Beijing. from Reuters: Business News… Read More
Trump is pressing the nuclear option on tariffs
The option of a 20% universal tariff is the only way to get to some of the massive revenues of trillions of dollars claimed by some of his a...
0 comments:
Post a Comment